SCD vascular inflammation is caused by microthrombotic events of TF expressed by myelomonocytic cells (Mo) and amplified by abnormal red blood cells and/or activated platelets. Noncoagulant endothelial cell (EC) TF-dependent FXa-PAR2 signaling contributes independently to inflammation by increasing circulating levels of IL-6.